NEW YORK (GenomeWeb) – Roche said today that its diagnostics revenues grew 6 percent year over year for the first quarter of 2017, driven by growth in its centralized and point-of-care solutions segment.

For the three months ended March 31, the Swiss pharmaceutical and diagnostics company reported overall revenues of CHF 12.94 billion ($13.07 billion), up 4 percent from CHF 12.41 billion in Q1 2016.

In diagnostics, Roche reported revenues of CHF 2.77 billion, up from CHF 2.61 billion in 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.